Give Now

Eli Lilly Announces $140 Million Expansion In Indianapolis

Eli Lilly employees run tests in a laboratory.

Eli Lilly has announced a $140-million expansion of its Indianapolis insulin manufacturing facility.

The new facility will manufacture insulin cartridges to meet the growing diabetes demand in the U.S. Company officials say it is one of the most significant investments in its U.S.-based manufacturing operations in the past 10 years and will be a first-of-its-kind facility for Lilly in the U.S.

Eli Lilly president of global manufacturing Maria Crowe says Lilly decided to add insulin-cartridge manufacturing to its Indianapolis plant, rather than expand existing operations in Europe. The facility will employ 100 full-time workers once it is fully operational. Construction should be complete in March 2014.

Want to contact your legislators about an issue that matters to you? Find out how to contact your senators and member of Congress here.

What is RSS? RSS makes it possible to subscribe to a website's updates instead of visiting it by delivering new posts to your RSS reader automatically. Choose to receive some or all of the updates from Indiana Public Media News:

Support For Indiana Public Media Comes From